Epidermal growth factor receptor (EGFR) is an important gene in the development of lung
adenocarcinoma. However, there is controversy regarding the association between EGFR …

Purpose The purpose of this study was to investigate the relationship between epidermal
growth factor receptor (EGFR) gene mutation and clinicopathological features of lung …

The purpose of this study was to evaluate the association between epidermal growth factor
receptor (EGFR) mutations and prognosis in patients with completely resected lung …

7574 Background: Prognostic impact of epidermal growth factor receptor (EGFR) gene
mutations in lung adenocarcinoma remains controversial. We examined a large cohort of …

The aim of the present study was to investigate the mutation rate of the epidermal growth
factor receptor (EGFR) in non‑small cell lung cancer (NSCLC) patients and to apply logistic …

Aim With the advent of the molecular‐targeted therapy, rapid progress has been made in the
treatment of advanced or recurrent non‐small‐cell lung cancer (NSCLC). Although surgical …

Objective To investigate epidermal growth factor receptor (EGFR) gene mutations in exons
19 and 21 of patients with non-small cell lung cancer (NSCLC) and to analyze the …

Background The prognostic role of epidermal growth factor receptor (EGFR) mutations in
patients with lung adenocarcinomas remains controversial and the association between …

Purpose: It has been reported that the mutations of epidermal growth factor receptor (EGFR)
are detected in lung cancers. Studies of EGFR mutations in large numbers of patients' …

The epidermal growth factor receptor (EGFR) mutation status has become one of the most
important factors in the treatment of non-small cell lung cancer. However, the relationship …